|
|
| (4 intermediate revisions by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Nifedipine#Pharmacology]] |
| {{Nifedipine}}
| |
| {{CMG}}; {{AE}}: {{AK}}
| |
| | |
| '''''For patient information about Nifedipine, click [[Nifedipine (patient information)|here]].'''''
| |
| | |
| ==CLINICAL PHARMACOLOGY==
| |
| | |
| Nifedipine is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac muscle and smooth muscle. The contractile processes of cardiac muscle and vascular smooth muscle are dependent upon the movement of extracellular calcium ions into these cells through specific ion channels. Nifedipine selectively inhibits calcium ion influx across the cell membrane of cardiac muscle and vascular smooth muscle without altering serum calcium concentrations.
| |
| | |
| | |
| | |
| | |
| | |
| | |
| {{Reflist|2}}
| |
| http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03be089c-07e5-4f94-bfcc-c6101b311785
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |